Ranitidine and Eosinophil count increased - a phase IV clinical study of FDA data

Summary:

Eosinophil count increased is reported as a side effect among people who take Ranitidine (ranitidine), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Gravol, and have Relapsing-remitting multiple sclerosis.

The phase IV clinical study analyzes which people have Eosinophil count increased when taking Ranitidine. It is created by eHealthMe based on reports of 233,168 people who have side effects when taking Ranitidine from the FDA, and is updated regularly.

What is Ranitidine?

Ranitidine has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 234,475 Ranitidine users. Check the latest studies of Ranitidine.

What is Eosinophil count increased?

Eosinophil count increased is found to be associated with 768 drugs and 1,130 conditions by eHealthMe. Check the latest studies of Eosinophil count increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 22, 2026

233,168 people reported to have side effects when taking Ranitidine.
Among them, 130 people (0.06%) have Eosinophil count increased.

Could Ranitidine cause Eosinophil count increased?

Among these 130 people:

How long have people been on Ranitidine when they have Eosinophil count increased? *

Click here to view more results

What is the gender of people who have Eosinophil count increased when taking Ranitidine? *

Click here to view

What is the age of people who have Eosinophil count increased when taking Ranitidine? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Ranitidine and have Eosinophil count increased?

- Check whether Eosinophil count increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ranitidine:

Ranitidine (234,475 reports)

Eosinophil count increased treatments and more:

Eosinophil count increased (11,903 reports)

How severe was Eosinophil count increased and when was it recovered:

Eosinophil count increased in Ranitidine

Expand to all the drugs that have ingredients of ranitidine:

Eosinophil count increased and drugs with ingredients of ranitidine (131 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ranitidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eosinophil count increased:

Eosinophil count increased (768 drugs)

Browse all the conditions that are associated with Eosinophil count increased:

Eosinophil count increased (1,130 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ranitidine (the active ingredients of Ranitidine) and Ranitidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.